arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ARTIVION, INC.

AORT
$23.52 ▼ -0.62 (-2.57%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
43
Health
Weak
Neutral
auto_awesome

Analytical Summary

ARTIVION, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.1B
Dividend Yield —
Revenue Growth 13.6% ↗
Op. Margin 7.6% ↘
ROIC 3.4% ↘
FCF / Share $0.02 ↘
Trailing P/E 106.9x
Price / Book 2.4x
FCF Yield 0.1%
Debt / Equity 0.48
info Valuation on last close. End-of-day price, Sep 23, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$441.33M
↑ +13.6% —
Net Income Profit after all expenses
$9.77M
↑ +173.1% —
Operating Margin Operating profit as % of sales
7.6%
↓ -23.6% 51th
FCF / Share Free cash flow per share
$0.02
↓ -93.0% —
Long-Term Debt Long-term obligations
$215.11M
↓ -31.6% —

Health Breakdown

Profitability ↑
39
Returns
48
Financial Health ↓
52
Cash Quality ↓
25

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 18 years · 68 quarters